Evidence map›Paper›PMID 22078881›Full record

ArticleCell2011

NCoR1 is a conserved physiological modulator of muscle mass and oxidative function.

Hiroyasu Yamamoto, Evan G Williams, Laurent Mouchiroud, Carles Cantó, Weiwei Fan, Michael Downes, Christophe Héligon, Grant D Barish, Béatrice Desvergne, Ronald M Evans and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 1 synthesis or guideline pooled it, 259 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Run for your sons: paternal exercise boosts offspring fitness.Trends in endocrinology and metabolism: TEM · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Estrogen-related receptors regulate innate and adaptive muscle mitochondrial energetics through cooperative and distinct actions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Hiroyasu YamamotoLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Evan G Williams
Laurent Mouchiroud
Carles Cantó
Weiwei Fan
Michael Downes
Christophe Héligon
Grant D Barish
Béatrice Desvergne
Ronald M Evans
Kristina Schoonjans
Johan Auwerx
Howard Hughes Medical Institute · USUniversity of Lausanne · CHÉcole Polytechnique Fédérale de Lausanne · CHSalk Institute for Biological Studies · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
ProteomicsU19DK062434 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI QIN, JUN · 2002 to 2011
$37.4M
TISSUE COACTIVATOR AND RECEPTOR EXPRESSION FINGERPRINTSP01DK059820 · NIDDK · INSTITUT DE GENETIQUE ET BIOLOGIE MOLECU · PI O'MALLEY, BERT W · 2001 to 2016
$23.1M
HORMONAL REGULATION OF MAMMALIAN GENE EXPRESSIONR37DK057978 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 2000 to 2019
$16.0M
Spatial Regulation of Developmental Gene ExpressionR01HL105278 · NHLBI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 2011 to 2019
$4.0M
SPATIAL REGULATION OF DEVELOPMENTAL GENE EXPRESSIONR01HD027183 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 1990 to 2009
$3.6M
Hormonal Regulation of Mammalian Gene ExpressionR01DK057978 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 2021 to 2024
$2.6M
Repressor-PPAR Interactions in Inflammation and AtherosclerosisK08HL092298 · NHLBI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI BARISH, GRANT D · 2009 to 2013
$609k
European Research Council 231138Howard Hughes Medical InstituteNCI NIH HHS P30 CA014195NHLBI NIH HHS 1K08HL092298NHLBI NIH HHS K08 HL092298NHLBI NIH HHS R01 HL105278NICHD NIH HHS HD027183NICHD NIH HHS R01 HD027183NIDDK NIH HHS DK057978NIDDK NIH HHS DK059820NIDDK NIH HHS DK062434NIDDK NIH HHS P01 DK059820NIDDK NIH HHS R01 DK057978NIDDK NIH HHS R37 DK057978NIDDK NIH HHS U19 DK062434
6 · The paper itself

Abstract

Transcriptional coregulators control the activity of many transcription factors and are thought to have wide-ranging effects on gene expression patterns. We show here that muscle-specific loss of nuclear receptor corepressor 1 (NCoR1) in mice leads to enhanced exercise endurance due to an increase of both muscle mass and of mitochondrial number and activity. The activation of selected transcription factors that control muscle function, such as MEF2, PPARβ/δ, and ERRs, underpins these phenotypic alterations. NCoR1 levels are decreased in conditions that require fat oxidation, resetting transcriptional programs to boost oxidative metabolism. Knockdown of gei-8, the sole C. elegans NCoR homolog, also robustly increased muscle mitochondria and respiration, suggesting conservation of NCoR1 function. Collectively, our data suggest that NCoR1 plays an adaptive role in muscle physiology and that interference with NCoR1 action could be used to improve muscle function.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGene DeletionGene Knockdown TechniquesHumansMiceMitochondria, MuscleMuscle DevelopmentMuscle, SkeletalNuclear Receptor Co-Repressor 1Physical Conditioning, AnimalPPAR-betaPPAR deltaCaenorhabditis elegans ProteinsNcor1 protein, mouseNuclear Receptor Co-Repressor 1PPAR-betaPPAR delta

Identifiers

PMID22078881
PMCPMC3225739
OpenAlexW2002030208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.